Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment

Abstract Objectives Clinicians worldwide struggle to identify the bacterial aetiology of bone and joint infections. Failure to unequivocally identify the pathogen is linked to poor clinical outcomes. We explored the added value of analysing multiple samples per patient with 16S ribosomal DNA (16S rD...

Full description

Bibliographic Details
Main Authors: Katja Wallander, Martin Vondracek, Christian G. Giske
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Research Notes
Subjects:
Online Access:https://doi.org/10.1186/s13104-022-05992-7
_version_ 1818353599971852288
author Katja Wallander
Martin Vondracek
Christian G. Giske
author_facet Katja Wallander
Martin Vondracek
Christian G. Giske
author_sort Katja Wallander
collection DOAJ
description Abstract Objectives Clinicians worldwide struggle to identify the bacterial aetiology of bone and joint infections. Failure to unequivocally identify the pathogen is linked to poor clinical outcomes. We explored the added value of analysing multiple samples per patient with 16S ribosomal DNA (16S rDNA) sequencing in diagnosing postoperative bone and joint infections. All patients had received antimicrobials prior to sampling, and false-negative cultures could be suspected. Bone biopsies obtained from patients with postoperative bone and joint infections for cultures were also subjected to 16S rDNA sequencing. Results In 5/28 infectious episodes, sequencing identified the causative organism of the infection when cultures failed. In 8/28 episodes, the methods led to different results, potentially leading to different antimicrobial choices. The analysis of multiple samples per patient helped rule out potential contaminating pathogens. We conclude that 16S rDNA sequencing has diagnostic value for patients receiving antibiotic treatment. We regard the method as a complement to culturing when the cultures are negative. Multiple samples per patient should be analysed to determine the clinical significance of positive findings.
first_indexed 2024-12-13T19:12:06Z
format Article
id doaj.art-1e204b7eaf6a4ad3aabfc88c09c4388a
institution Directory Open Access Journal
issn 1756-0500
language English
last_indexed 2024-12-13T19:12:06Z
publishDate 2022-03-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj.art-1e204b7eaf6a4ad3aabfc88c09c4388a2022-12-21T23:34:22ZengBMCBMC Research Notes1756-05002022-03-011511610.1186/s13104-022-05992-7Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatmentKatja Wallander0Martin Vondracek1Christian G. Giske2Department of Infectious Diseases and Venhälsan, SödersjukhusetDepartment of Clinical Microbiology, Karolinska University Hospital StockholmDepartment of Clinical Microbiology, Karolinska University Hospital StockholmAbstract Objectives Clinicians worldwide struggle to identify the bacterial aetiology of bone and joint infections. Failure to unequivocally identify the pathogen is linked to poor clinical outcomes. We explored the added value of analysing multiple samples per patient with 16S ribosomal DNA (16S rDNA) sequencing in diagnosing postoperative bone and joint infections. All patients had received antimicrobials prior to sampling, and false-negative cultures could be suspected. Bone biopsies obtained from patients with postoperative bone and joint infections for cultures were also subjected to 16S rDNA sequencing. Results In 5/28 infectious episodes, sequencing identified the causative organism of the infection when cultures failed. In 8/28 episodes, the methods led to different results, potentially leading to different antimicrobial choices. The analysis of multiple samples per patient helped rule out potential contaminating pathogens. We conclude that 16S rDNA sequencing has diagnostic value for patients receiving antibiotic treatment. We regard the method as a complement to culturing when the cultures are negative. Multiple samples per patient should be analysed to determine the clinical significance of positive findings.https://doi.org/10.1186/s13104-022-05992-7DNA sequencingArthritis bacterialOsteomyelitisCoinfectionProsthesis-related infection
spellingShingle Katja Wallander
Martin Vondracek
Christian G. Giske
Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
BMC Research Notes
DNA sequencing
Arthritis bacterial
Osteomyelitis
Coinfection
Prosthesis-related infection
title Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
title_full Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
title_fullStr Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
title_full_unstemmed Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
title_short Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
title_sort evaluation of multi sample 16s ribosomal dna sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
topic DNA sequencing
Arthritis bacterial
Osteomyelitis
Coinfection
Prosthesis-related infection
url https://doi.org/10.1186/s13104-022-05992-7
work_keys_str_mv AT katjawallander evaluationofmultisample16sribosomaldnasequencingforthediagnosisofpostoperativeboneandjointinfectionsduringantimicrobialtreatment
AT martinvondracek evaluationofmultisample16sribosomaldnasequencingforthediagnosisofpostoperativeboneandjointinfectionsduringantimicrobialtreatment
AT christianggiske evaluationofmultisample16sribosomaldnasequencingforthediagnosisofpostoperativeboneandjointinfectionsduringantimicrobialtreatment